Quinoxaline 1,4-dioxides: Hypoxia-selective therapeutic agents

Molecular Carcinogenesis

Volumn 33, Issue 4, 2002, Pages 198-205

  Diab Assef, Mona ^a   Haddadin, Makhluf J ^a   Yared, Pierre ^a   Assaad, Chafika ^a   Gali Muhtasib, Hala U ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Bioreductive drugs; Hypoxia; Hypoxia cytotoxicity ratio; Hypoxia inducible factor 1 ; Quinoxaline 1,4 dioxides

Indexed keywords

2 ACETYL 3 METHYLQUINOXALINE 1,4 DIOXIDE; 2 BENZOYL 3 PHENYL 6,7 DICHLOROQUINOXALINE 1,4 DIOXIDE; 2 BENZOYL 3 PHENYLQUINOXALINE 1,4 DIOXIDE; 2,3 TETRAMETHYLENE QUINOXALINE 1,4 DIOXIDE; ANTINEOPLASTIC AGENT; QUINOXALINE 1,4 DIOXIDE DERIVATIVE; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; COLON CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; HUMAN; HUMAN CELL; HYPOXIC CELL; PRIORITY JOURNAL; SOLID TUMOR;

AEROBIOSIS; ANTINEOPLASTIC AGENTS; CELL HYPOXIA; CELL SURVIVAL; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS; QUINOXALINES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0036214054     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10036     Document Type: Article

References (26)

1. The hypoxic cell: A target for selective cancer therapy - Eighteenth Bruce F. Cain Memorial Award lecture
2. The hypoxic tumor cell: A target for selective cancer chemotherapy
3. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors
4. 2 tension
5. Relationship of hypoxia-inducible factor (HIF)-1α and HIF-2α expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines
6. Role of HIF-1 in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
7. Tumor hypoxia: The picture has changed in the 1990s
8. SR-4233: A new bioreductive agent with high selective toxicity for hypoxic cells
9. Quinoxaline 1,4-dioxides as anticancer and hypoxia-selective drugs
10. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides
11. Cytogenetic effects of quinoxaline-1,4-dioxide growth-promoting agents. III. Transplacental micronucleus test in mice
12. Antibacterial properties of quindoxin: A new growth-promoting agent
13. The effect of quindoxin on the growth of broiler chickens
14. Genotoxicity of quinoxaline 1,4-dioxide derivatives in Escherichia coli and Salmonella typhimurium
15. Mode of action of quindoxin and substituted quinoxaline-di-N-oxides on Escherichia coli
16. Free radical intermediates in the reduction of quinoxaline N-oxide antitumor drugs: Redox and prototropic reactions
17. Application of benzofurazan oxide to the synthesis of hetero-aromatic N-oxides
18. The Beirut reaction
19. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
20. Chemical properties which control selectivity and efficacy of aromatic N-oxide bioreductive drugs
21. Suppression of tumor growth through disruption of hypoxia-inducible transcription
22. Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs. Part 1.8-Alkylamino-substituted phenylimidazo [1,2-a]quinoxalines
23. 1,2,4-Benzotriazine 1,4-dioxides. An important class of hypoxic cytotoxins with antitumor activity
24. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin
25. The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay
26. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells